Executive Spotlight: Darryl Munden, Chief Operating Officer
We recently sat down with Darryl Munden, Chief Operating Officer,to discuss his view of the evolving industry landscape and learn more about his ...
We recently sat down with Darryl Munden, Chief Operating Officer,to discuss his view of the evolving industry landscape and learn more about his ...
In the wake of the class action brought against Johnson & Johnson (J&J), alleging breach of fiduciary duties, the pharmacy benefit management (PBM)...
More than ten biosimilars to Humira® were launched in 2023, introducing price competitiveness for one of the most utilized drugs on the market....
As Navitus Health Solutions celebrates its twenty-year legacy and looks ahead to the future, an area of focus is workplace culture. Our people are...
This summer, Navitus celebrated its 20th anniversary as an organization. In honor of that, we sat down with David Fields to reflect on the company's...
2023 is a year of celebration at Navitus. Not only is it the 20th anniversary of our founding, but 2023 also marks 10 years of Navitus' residency...
Our recent August Pharmacy and Therapeutics (P&T) Committee meeting reviewed the release of various Humira® biosimilars. Staying true to our...
In an ever-changing legislative landscape, we want to help our clients and partners stay informed of the latest happenings and how proposed policies...
This summer has seen a continuation of the long-awaited market entry of Humira® (adalimumab) biosimilars. As of July 1, nine additional biosimilars...
We are pleased to share our 2022 Drug Trend Report with you. This year's report highlights our success in managing pharmacy benefit costs for our...
We had the pleasure of connecting with our new Chief Financial Officer, George Hepburn, to discuss what excites him about his new role, what inspires...
We recently sat down with Ken Goodnight to discuss his key priorities as Chief Transformation & Digital Officer and to learn about his professional...
Copyright © 2022 Navitus
All rights reserved